oral semaglutide weight loss studies Long-term effects of in obesity without diabetes in the SELECT trial Frontiers | Oral semaglutide for

Most have been conducted in individuals with type 2 diabetes who were also receiving medications such as metformin, which may independently affect the gut microbiome

And it is largely preventable with the right approach

The possibility that GLP-1 medicines could reduce craving or alter reward-related behaviour has become an active area of investigation, particularly as these drugs become more widely used for diabetes, obesity and weight management

The GLP-1 meals shared here do just that

It works by decreasing the amount of glucose (sugar) produced by the liver and improving the bodys sensitivity to insulin

Peptides 151 , 170749 (2022)